The table below is a review of notable updates that occurred in November 2024 for investigational products in development (not an inclusive list). Click on the status to view our full coverage. The ...
A generic latanaprost solution from Gland Pharma has received FDA approval for the treatment of open angle glaucoma and ocular hypertension.
Supplements for retinitis pigmentosa have not demonstrated any high-quality evidence to support the effectiveness in slowing disease progression.